Kangsang Lee is Assistant Professor of Chemistry at the University of Central Florida's College of Sciences. His research develops novel synthetic methods in organosilicon chemistry and polymer science. Recent work explores catalytic C-H silylation techniques and silicone-acrylate copolymer systems with applications in advanced materials and conductive coatings. His group investigates fundamental reaction mechanisms while developing practical synthetic protocols.
Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.
David H. Sherman is the Hans W. Vahlteich Professor of Medicinal Chemistry at the University of Michigan, holding joint appointments in the College of Pharmacy (Department of Medicinal Chemistry), Medical School (Microbiology & Immunology), and College of Literature, Science, and the Arts (Chemistry). He leads the Sherman Lab at the Life Sciences Institute and co-founded the Natural Products Discovery Core. His research focuses on natural product discovery, biosynthetic pathways, and drug development for infectious diseases, cancer, and neurological disorders. Education: PhD in Synthetic Organic Chemistry from Columbia University (1981), BA in Chemistry from UC Santa Cruz (1978). Postdoctoral research at MIT (1984). Research interests include microbial secondary metabolites, enzymatic catalysis (e.g., C-H functionalization, polyketide assembly), and high-throughput drug screening. He pioneered a microbial natural product library with over 50,000 samples. Current projects emphasize developing macrolide antibiotics and advancing compounds toward clinical trials through the Natural Products Biosciences Initiative. Collaborations span global institutions, with a focus on biodiversity conservation and capacity-building in low-income nations. He has mentored 67 PhD students, 60 postdocs, and 85+ undergraduates, fostering interdisciplinary training in chemical biology and microbial biochemistry. Labs/Teams: Sherman Lab (Life Sciences Institute), Center Member at Samuel and Jean Frankel Cardiovascular Center, Center for Computational Medicine and Bioinformatics, Rogel Cancer Center.
David John Procter is a Professor of Organic Chemistry and Head of the Department of Chemistry at the University of Manchester. His career includes academic roles at the University of Glasgow (Lecturer, Senior Lecturer) and a Readership at the University of Manchester, where he became a Professor in 2008. His research focuses on developing new synthetic methods, catalysis, and materials chemistry, with applications in drug discovery, biocatalysis, and organic electronics. Education: BSc Chemistry (University of Leeds, 1992), PhD (1995, supervised by Prof. Christopher Rayner). Postdoctoral work: Florida State University (Prof. Robert Holton, Taxol analog synthesis). Research interests include samarium diiodide-mediated reactions, metal-free coupling processes, and sustainable synthesis methods. He leads projects funded by EPSRC, Industry (30 grants), and international collaborations. Awards include the EPSRC Established Career Fellowship (2015–2020), Bader Prize (2014), and Young Heterocyclic Chemist Award (2015). Key contributions: Total synthesis of natural products (e.g., pleuromutilin), development of copper-catalyzed multicomponent couplings, and innovative methods for organic materials. His work aligns with UN Sustainable Development Goals related to affordable and clean energy and responsible consumption. Collaborations span academic and industrial partnerships in chemistry, physics, and biology. He supervises 60+ students and contributes to the Organic Materials Innovation Centre (OMIC). His group’s research is detailed at proctergroupresearch.com .
Dr. Monica E. McCallum is an Assistant Professor of Chemistry in the Department of Chemistry at the University of Pennsylvania’s School of Arts & Sciences. Her research focuses on understanding the biochemical origins of natural products and their roles in microbial communication. She leads the McCallum Lab, which employs interdisciplinary approaches combining organic synthesis, biochemistry, microbiology, and microscopy to study microbial natural products in their native contexts. Education: 2016 – Postdoctoral Fellow at Harvard University under Prof. Emily P. Balskus 2016 – PhD in Organic Chemistry from Baylor University 2013 – PhD Candidate at Colorado State University 2011 – B.S. in Chemistry from University of California, Irvine Research Interests: Dr. McCallum’s work bridges organic synthesis and microbiology to decode microbial metabolite functions. Key themes include: Synthesizing complex natural products and their biosynthetic precursors Discovering novel enzyme-catalyzed reactions Unraveling microbial communication mechanisms via natural products Investigating environmental microbial community dynamics Lab & Collaborations: The McCallum Lab emphasizes interdisciplinary collaboration, integrating techniques from organic chemistry, molecular biology, and microscopy to study natural products in situ. Current projects focus on diazeniumdiolate biosynthesis pathways and enzymatic detoxification of marine toxins.
Ulf Hanefeld is a Full Professor and Section Leader in the Department of Biotechnology at the Faculty of Applied Sciences , Delft University of Technology (TU Delft) , where he leads the Biocatalysis research section. His work integrates chemistry and biology to develop sustainable synthetic methodologies using enzymes. PhD from Georg-August-Universität zu Göttingen (1993) Postdoctoral experience at Imperial College London, University of Cambridge, and TU Delft Recipient of a Royal Netherlands Academy of Arts and Sciences (KNAW) fellowship His research interests center on biocatalysis , particularly enzymes that enable difficult chemical transformations such as C–C bond formation , enantioselective hydration , and ozonolysis . He focuses on enzyme discovery, engineering, immobilization, and application in flow chemistry to achieve sustainable and efficient synthesis. His work spans from fundamental enzyme mechanism studies to industrial applications in green chemistry . The publication trends reveal a consistent focus on enzyme immobilization , flow reactor systems , and chemo-enzymatic cascades . His recent work emphasizes the use of hydroxynitrile lyases , aldolases , and methyltransferases for the synthesis of chiral intermediates under environmentally benign conditions. The integration of biocatalysis with continuous manufacturing highlights a strong commitment to industrial applicability and process sustainability. Scientific contributions and recognition : Active contributor to high-impact journals in chemistry and biotechnology Coordinated research in the CassaFLOW project (international academic-industrial collaboration) Author of influential reviews, e.g., in Chemical Society Reviews (2022) Teaching and supervision : He teaches Catalysis (Bachelor) and Advanced Biocatalysis (Master), and supervises numerous Master’s theses (MEP) and Bachelor’s projects (BEP) . Students in his group are actively involved in research and often become co-authors on scientific papers. Projects center on green chemistry, enzyme engineering, and spectroscopic analysis of biochemical systems. Laboratory and research environment : The Ulf Hanefeld Group operates within the Biocatalysis section, a multidisciplinary environment fostering collaboration on enzyme discovery, immobilization, and cascade reactions. The group emphasizes practical innovation, with strong links to industry and international research networks.
Prof. Dr. Oliver Reiser is a full Professor at the Institute of Organic Chemistry within the Faculty of Chemistry and Pharmacy at the University of Regensburg. His research group focuses on cutting-edge developments in organic synthesis, particularly in the areas of photocatalysis and visible light chemistry. He leads the Collaborative Research Centre CRC 325 on "Assembly Controlled Chemical Photocatalysis," which aims to develop new frontiers in photocatalysis for organic synthesis through designed control of catalyst-substrate interactions. University of Hamburg (PhD, 1989) IBM Research Center (Postdoc) Harvard University (Postdoc) University of Göttingen (Habilitation, 1995) Prof. Reiser's research spans multiple interconnected fields with a strong emphasis on sustainable chemistry. His group extensively utilizes modern techniques for organic synthesis including flow reactors, microwaves, and high-pressure systems. The primary research thrusts include catalysis (both metal and organocatalysts), unnatural amino acids and peptide foldamers, and natural product synthesis. His work on visible light photocatalysis has been particularly influential, with numerous publications in high-impact journals like Angewandte Chemie and Nature Catalysis. The group's research integrates experimental, spectroscopic, and computational techniques to analyze catalyst-substrate interactions for more rational design of photochemical reactions. Analysis of Prof. Reiser's recent publications (2023-2025) reveals a strong focus on copper-based photocatalysis, sustainable chemistry using earth-abundant metals, and innovative approaches to heterocycle synthesis. His work demonstrates a clear trend toward developing more efficient and environmentally friendly catalytic processes, with particular emphasis on visible light activation, catalyst immobilization for recyclability, and applications in medicinal chemistry. The research spans from fundamental mechanistic studies to practical applications in synthesis. German Academic Scholarship Foundation Minerva Foundation NATO Fellowship German Research Foundation Support Karl Winnacker Foundation Prof. Reiser has supervised numerous doctoral students, with recent PhD theses focusing on copper photoredox catalysis, magnetic nanoparticle-supported catalysts, and the synthesis of bioactive compounds. His research is supported by multiple collaborative projects, including the Collaborative Research Centre CRC 325, and involves extensive national and international collaborations with institutions such as the University of Kansas, the National Institute of Chemistry in Pune, the Institut Chimie de Coordination du CNRS in Toulouse, and the University of Zaragoza. The group maintains strong ties with pharmaceutical research through collaborations with Prof. A. Beck-Sickinger in Leipzig on neuropeptide ligands. The research group operates well-equipped laboratories with capabilities for advanced organic synthesis and characterization. They have developed specialized expertise in flow chemistry, high-pressure techniques, and magnetic nanoparticle-based catalyst systems. The CRC 325 initiative has provided significant infrastructure for collaborative research in photocatalysis, bringing together multiple research groups with complementary expertise in organic synthesis, spectroscopy, and computational chemistry.
Ron Dror is the Cheriton Family Professor of Computer Science at the Stanford Artificial Intelligence Lab , with courtesy appointments in Structural Biology and Molecular & Cellular Physiology . He also holds affiliations with Bio-X, the Institute for Human-Centered Artificial Intelligence (HAI), the Institute for Computational and Mathematical Engineering (ICME), Sarafan ChEM-H, and the Wu Tsai Neurosciences Institute. Education: PhD in Electrical Engineering and Computer Science, MIT MPhil in Biological Sciences, University of Cambridge (Churchill Scholar) BS in Mathematics and Electrical & Computer Engineering, Rice University (summa cum laude) Ron leads a multidisciplinary research group that combines molecular simulation and machine learning to study biomolecular structure, dynamics, and function. His work focuses on developing computational methods to accelerate drug discovery by predicting molecular interactions and designing more effective therapeutics. Current projects include the PENSA software library for analyzing biomolecular ensembles and FRAME framework for structure-based ligand design. His research has produced groundbreaking work on G-protein-coupled receptors (GPCRs) , RNA structure prediction , and mitochondrial transport mechanisms . Key publications highlight applications of geometric deep learning and molecular dynamics simulations in structural biology. Scientific Awards: Cheriton Family Professorship (2023) Two Gordon Bell Prizes (2014, 2009) Best Paper Awards at NeurIPS (2021), IPDPS (2013), SC11 (2011), SC09 (2009), SC06 (2006) Science Magazine Top 10 Breakthrough (2010) Fulbright Scholarship , NSF Fellowship , DoD Fellowship , Whitaker Foundation Fellowship Ron has advised numerous doctoral and master’s students including EJ Fine , Masha Karelina , and Briana Sobecks . His lab collaborates with experimentalists across academia and industry, applying computational methods to diverse biomedical problems such as RNA structure prediction , GPCR signaling , and mitochondrial metabolism .
Amy E. Fraley is an Assistant Professor at ETH Zürich, Department of Chemistry and Applied Biosciences, and leads the Medicinal Chemistry Research Group. Her cross-disciplinary work bridges natural products biosynthesis, pharmaceutical sciences, and environmental sustainability through enzymatic chemistry and biotechnology. BSc in Chemistry, Millersville University of Pennsylvania (2014) PhD in Medicinal Chemistry, University of Michigan College of Pharmacy (2019) Postdoctoral work at ETH Zürich Institute of Microbiology under Prof. Jörn Piel Her research focuses on harnessing biosynthetic enzymes (e.g., halogenases, monooxygenases, Diels-Alderases) to create sustainable bioactive metabolites. She explores natural product biosynthesis in fungi and marine bacteria, targeting disease mechanisms and green chemistry applications. Recent work includes metagenomic studies of Lake Chilika microbial mats and polyketide synthase engineering. Notable scientific awards include the 2024 JSP Fellow at Bürgenstock Conference, 2018 Rackham Predoctoral Fellowship, and multiple University of Michigan honors. Her group secured funding from the ETH4D Doctoral Mentorship Grant and Messerli Foundation . Collaborations span structural biology, synthetic chemistry, and microbiology, with key contributions to flavoenzyme characterization and bioactive compound libraries . The lab emphasizes interdisciplinary training and innovation in biocatalytic tools for organic synthesis.
Prof. Dr. Armido Studer is a Full Professor of Organic Chemistry at the Institute of Organic Chemistry, Faculty of Mathematics and Natural Sciences, University of Münster (WWU Münster), Germany. He has been serving as a Full Professor (W3) since November 2009, following his appointment as a Full Professor (C4) in 2004. Studer also serves as the Spokesman of the International Research Training Group IRTG 2678 'Functional π-Systems: Activation, Interaction and Application (pi-Sys)' since 2021 and previously led the Collaborative Research Center SFB 858 'Synergetic Effects in Chemistry - From Additivity towards Cooperativity' from 2010 to 2021. Studer received his education at ETH Zürich, where he completed his diploma thesis and doctoral studies under Prof. Dr. D. Seebach. He conducted postdoctoral research at the University of Pittsburgh with Prof. Dr. D. P. Curran before returning to ETH Zürich for his habilitation. His academic career includes positions as Associate Professor at Philipps-Universität Marburg (2000-2004) and subsequent professorships at WWU Münster. Professor Studer's research focuses on radical chemistry, particularly in the development of new synthetic methods using radical intermediates. His work spans free radical chemistry, electron catalysis, and the application of nitroxides in organic synthesis. Recent research directions include 'Radical Chemistry with the Hydrogen Atom Through Water Activation (H-dot)' and 'The Electron as a Catalyst: e-cat', both funded by ERC Advanced Grants. His group has made significant contributions to C-H functionalization, skeletal editing of heterocycles, and cooperative catalysis involving photoredox and N-heterocyclic carbene systems. The research has applications in pharmaceutical chemistry, materials science, and sustainable chemical synthesis. Studer's publication record shows a strong focus on heterocyclic chemistry, radical reactions, and catalytic methodologies. His recent work demonstrates expertise in meta-selective functionalization of heteroarenes, skeletal editing techniques, and the development of novel radical cascade reactions. The group has published extensively in high-impact journals including Nature, Science, JACS, and Angewandte Chemie. Adolf-von-Baeyer-Denkmünze (2025) Arthur C. Cope Late Career Scholars Award of the American Chemical Society (2024) ERC Advanced Grants (2024, 2016) Multiple Highly Cited Researcher designations (2017-2022) Elected member of multiple academies (European Academy of Sciences, Academia Europaea, German National Academy of Sciences Leopoldina) Pedler Award of the Royal Society of Chemistry (2019) Professor Studer has mentored over 100 PhD students and postdoctoral researchers who have gone on to successful careers in academia and industry worldwide. His research is supported by significant grants including multiple ERC Advanced Grants and funding from the German Research Council (DFG) for collaborative research centers. The Studer Group maintains numerous international collaborations, particularly with institutions in Japan, China, and the United States, reflecting his global impact in organic chemistry. The Studer Group operates state-of-the-art laboratories at the University of Münster, equipped for advanced organic synthesis, photochemistry, and materials characterization. The group is known for its collaborative culture and has been featured in numerous group photos documenting its evolution since the early 2000s, first at Philipps-Universität Marburg and then at WWU Münster.
Professor George Britovsek (FRSC) is a leading figure in catalysis and sustainable carbon management at Imperial College London . As Director of the MRes in Catalysis & Engineering and Head of Teaching in Inorganic Chemistry, he bridges academic leadership with cutting-edge research. His work focuses on transition metal complexes for converting ethylene , alkanes , biomass , and CO₂ into valuable chemicals and fuels through industrial collaborations. Education : M.Sc. (Technical University of Aachen, 1990), Ph.D. (Aachen, 1993) under Prof. W. Keim Postdoctoral Training : University of Tasmania (1994-1996), Imperial College London (1996-2000) His research interests span: Selective oxidation of alkanes using bio-inspired iron complexes Alkene conversions to functional polymers via novel catalysts CO₂ valorization into polymers and cyclic carbonates Biomass-derived feedstocks for chemical synthesis Recent catalysis trends highlight his work on: Designing Fe-N/C catalysts for epoxidation Developing PN3P pincer ligands for H₂ activation Creating degradable polyethylene via iron-catalyzed chain growth Modeling alternating α-olefin distributions in chromium systems Awards : Fellow of the Royal Society of Chemistry (FRSC) Students & Collaborators actively engage in: Photocatalytic polymer degradation Electrocatalytic CO₂ conversion Functionalized polymeric materials 3D-printed catalytic scaffolds His Britovsek Research Group operates at the Molecular Sciences Research Hub, White City Campus, advancing both homogeneous and heterogeneous catalysis through experimental and computational approaches.
Megan L. Matthews is an Assistant Professor in the Department of Chemistry at the University of Pennsylvania, School of Arts & Sciences, where she leads an active research group focused on chemical biology and enzymology. Her lab develops innovative chemical proteomics technologies to uncover novel enzyme cofactors and regulatory post-translational modifications, particularly those involving reactive electrophiles, which cannot be predicted from genomic sequences. B.S. in Chemistry, Miami University (2005) Ph.D. in Chemistry, The Pennsylvania State University (2011) Postdoctoral Fellow, The Scripps Research Institute (2012–2017) Her research centers on the concept of the 'electrophilome'—a largely unexplored half of the reactive proteome. By designing 'reverse-polarity' chemical probes, her group enables the discovery of functionally significant electrophilic modifications in proteins, especially those involved in cancer and Alzheimer’s disease. These discoveries open new avenues for therapeutic intervention through covalent targeting. The recent publications demonstrate a consistent focus on enzyme mechanisms, cofactor discovery, and chemical probe development. Her work spans from fundamental enzymology (e.g., halogenases, ribonucleotide reductases) to applied chemical biology (e.g., hydrazine probes, chemoproteomic profiling). The keywords across her publications highlight emerging themes in metalloenzymes, radical chemistry, and covalent proteome mapping. Her scientific contributions have been recognized through prestigious fellowships, including the Merck Helen Hay Whitney Postdoctoral Fellowship. She has published in top-tier journals such as Nature , Nature Chemical Biology , and Journal of the American Chemical Society . Dr. Matthews advises graduate students and postdoctoral researchers in her lab, fostering a collaborative and inclusive environment. Her lab emphasizes the importance of diverse perspectives in scientific discovery. She has secured research funding to support projects in probe development, target characterization, and disease mechanism studies, particularly in neurodegenerative diseases and cancer. The Matthews Lab is actively engaged in advancing reverse-polarity activity-based protein profiling (RP-ABPP) for in vivo applications and inhibitor screening. The group collaborates with experts in structural biology, spectroscopy, and disease modeling to translate basic discoveries into therapeutic insights.
Dr. Jia Zhang is the Inaugural Robert H. Dedman Jr. Endowed Department Chair and Professor of Computer Science at Southern Methodist University (SMU Lyle School of Engineering). She holds the Cruse C. and Marjorie F. Calahan Centennial Chair in Engineering and has a courtesy appointment in the Department of Operations Research and Engineering Management. Her research focuses on applying machine learning, natural language processing, and information retrieval to data science infrastructure, particularly scientific workflows, provenance mining, software discovery, knowledge graphs, cloud computing, immune AI, and applications in earth science and healthcare. Education: Ph.D. in Computer Science, University of Illinois at Chicago M.S. in Computer Science, Nanjing University B.S. in Computer Science, Nanjing University Dr. Zhang's work emphasizes data science infrastructure and machine learning for scientific workflows and knowledge graphs. Her recent publications highlight deep learning , graph neural networks , and optimization algorithms in cloud computing, cybersecurity, and environmental applications. Key trends include spatiotemporal modeling , hybrid neural architectures , and AI-driven service ecosystems . Scientific Awards: Best Paper Awards IEEE SCC (2011, 2017) Best Student Paper Awards IEEE ICWS (2014, 2018), IEEE ICCC (2018) Distinguished Paper Award ICSOC (2023) First Outstanding Service Award IEEE Technical Committee on Services Computing (2016) She has secured over $5 million in federal grants (as PI) and $11 million as PI/Co-PI from NSF, NASA, NIH, UTSW, Ericsson, SAP, and Google. Her lab (Caruth Hall 308) actively recruits research assistants. She previously served as a faculty member at Carnegie Mellon University, Northern Illinois University, and Nanjing University, and worked in industry as a software architect.
Thomas Lectka is the Jean and Norman Scowe Professor in the Department of Chemistry at Johns Hopkins University, where he has been a faculty member since 1994. His research focuses on synthetic and physical organic chemistry, particularly in the area of organofluorine chemistry. PhD, Cornell University Postdoctoral Fellow, Heidelberg (Alexander von Humboldt Fellow) Postdoctoral Fellow, Harvard University (NIH Fellow) Dr. Lectka's research is centered on developing novel synthetic methods, especially for fluorination, and understanding the physical organic principles underlying reactivity. His work spans radical fluorination , catalytic asymmetric synthesis , and the design of fluorinated bioactive molecules . Using a combination of experimental and computational techniques, his lab investigates C-F bond formation , reaction mechanisms , and the biological applications of fluorinated compounds. His recent work, as reflected in publications from 2010 to 2024, shows a consistent trajectory in advancing fluorination methodologies, with increasing emphasis on site-selectivity , enantiocontrol , and biomedical relevance . Themes include the development of new reagents, mechanistic studies, and the synthesis of fluorinated natural product analogs and peptidomimetics. Dr. Lectka has received numerous honors and awards, including: ACS Arthur C. Cope Scholar (2024) ACS Maryland Chemist of the Year (2017) John Simon Guggenheim Memorial Fellowship Dreyfus Teacher-Scholar Award Sloan Fellowship NSF CAREER Award NIH First Award Eli Lilly Grantee Award He actively mentors graduate and undergraduate students in his research group, contributing to education and training in organic chemistry. His lab, The Lectka Group , is supported by grants from the NIH and NSF, enabling cutting-edge research in synthetic methodology and physical organic studies. The group fosters a collaborative environment focused on innovation in fluorine chemistry. The Lectka Group is an active research laboratory at Johns Hopkins University dedicated to pushing the boundaries of synthetic organic chemistry through the exploration of fluorine's unique properties. Current projects include site-selective radical fluorination and the synthesis of unusual fluorinated species, aiming to provide new tools for drug discovery and materials science.
Kay Severin is a full professor at the Laboratory of Supramolecular Chemistry (LCS) within École Polytechnique Fédérale de Lausanne (EPFL) , Switzerland. His research focuses on the design and reactivity of metal-ligand assemblies, including coordination cages, metalloligands, and supramolecular receptors. He has pioneered the use of metalloligands for constructing heterometallic architectures and developed systems for anion extraction and stimuli-responsive hydrogels. Key funder: Swiss National Science Foundation (FNS) Collaborative work with Rosario Scopelliti and Farzaneh Fadaei Tirani Research Interests: Severin's work spans supramolecular chemistry, organometallic synthesis, and functional materials. Recent projects include: Dynamic palladium-based hydrogels with anion-responsive crosslinks Gold(I)-driven nano-onion structures via π-stacking Triazene-derived ligands for Sandmeyer-type reactions Metalloligand assembly of Fe/Pd/Au heterotrimetallic cages Publication Trends: Over 300 publications since 1994, with recent emphasis on: Coordination-driven self-assembly (2024: 6 articles) Triazene and diazoolefin reactivity (2025: 4 articles) Metal-ligand interactions in nanogels and vesicles (2024-2025: 3 articles) Environmental applications in anion extraction (2025: 1 article)
